Cardinal Health Inc. stock (US14149Y1082): NYSE shares hold above key averages after earnings beat

Cardinal Health Inc. shares on the NYSE have been trading above important short-term moving averages following a better-than-expected quarterly earnings report, keeping the United States healthcare distributor in focus for investors watching price momentum and fundamentals.

Cardinal Health Inc. shares on the New York Stock Exchange have recently been changing hands well above key short-term moving averages after the United States healthcare group reported quarterly earnings that exceeded analyst expectations, keeping the stock in focus for domestic investors according to NYSE data and recent earnings coverage as of late May 2026.

The stock traded around USD 224.44 on 05/31/2026 on the NYSE under the ticker CAH, comfortably above a 20-day simple moving average near USD 194.41 and a 50-day average that also remained below the latest quote, highlighting an ongoing upward trend even as after-hours indications showed a softer quote around USD 196.80, according to NYSE price data, technical screens, and Reuters reporting as of 05/31/2026.

The price action comes in the wake of Cardinal Health's most recent quarterly release, where the company delivered earnings per share of USD 3.17 versus a consensus estimate of USD 2.79, alongside revenue growth of about 11 percent year on year, figures that MarketBeat summarized based on company filings and analyst estimates as of 06/02/2026.

The stock, which is part of the United States healthcare sector and trades on the NYSE in USD, has therefore been drawing renewed attention from investors who track both fundamental results and chart-based indicators to gauge how the business is performing in its home market.

As of: 06/02/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Cardinal Health
• Sector/industry: Healthcare distribution and services
• Headquarters/country: Dublin, United States
• Core markets: United States healthcare providers and pharmacies
• Key revenue drivers: Pharmaceutical distribution and medical products supply
• Home exchange/listing venue: New York Stock Exchange (CAH)
• Trading currency: USD

The stock traded at about USD 224.44 on 05/31/2026 on the NYSE, according to NYSE price data and Reuters technical screens as of 05/31/2026.

The same data set showed Cardinal Health's 20-day simple moving average near USD 194.41 and its 50-day moving average also below the latest closing quote at the end of May 2026, suggesting the shares have been holding above commonly watched short-term levels in the United States equity market.

Separate after-hours indications for 05/31/2026 cited a price around USD 196.80, roughly USD 3.05 or 1.53 percent below the regular-session level, underlining how extended-hours trading in the United States can diverge from the official close for NYSE-listed companies like Cardinal Health.

The earnings backdrop has helped frame this price performance, as MarketBeat reported that Cardinal Health generated earnings per share of USD 3.17 in its latest quarter compared with a consensus forecast of USD 2.79, while revenue grew approximately 11 percent year over year, according to a summarized analyst note published on 06/02/2026 that referenced the underlying company release.

MarketBeat also noted that analysts currently maintain an average rating of "Moderate Buy" on the stock with a consensus price target of about USD 241.80, indicating that, as of 06/02/2026, the research community continues to model further upside potential relative to the latest traded levels based on their compiled forecasts.

Cardinal Health Inc.: core business model

Cardinal Health positions itself as a large-scale healthcare logistics and products partner, primarily generating revenue by distributing pharmaceuticals and supplying medical products to hospitals, health systems, and retail pharmacies in the United States.

Latest quarterly results for Cardinal Health Inc. at a glance

In the most recent reported quarter, Cardinal Health delivered earnings per share of USD 3.17, surpassing the consensus estimate of USD 2.79 that MarketBeat compiled from analyst forecasts, a performance snapshot that was highlighted in a MarketBeat report dated 06/02/2026 and based on the company's earnings release.

The same MarketBeat summary stated that revenue in the quarter rose about 11 percent compared with the prior-year period, illustrating growth in the underlying distribution and products businesses, while also noting that the stock carried a consensus rating of "Moderate Buy" and a pooled analyst price target near USD 241.80 as of 06/02/2026, which provides additional context on how the earnings trajectory is feeding into United States sell-side expectations.

Conclusion

Cardinal Health's latest trading levels on the NYSE, which remain above key short-term moving averages, are being viewed in the context of a recent quarter in which the company exceeded consensus earnings expectations and posted double-digit revenue growth, based on NYSE data and MarketBeat's summary of the earnings figures as of late May and early June 2026.

For investors following the United States healthcare distribution space, the combination of supportive technical indicators, an earnings beat, and a consensus "Moderate Buy" rating with a pooled target price of about USD 241.80 underscores how both fundamentals and analyst views are shaping expectations for Cardinal Health without predetermining any specific share price outcome.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.